G209-2M; gp100 (209-217)

<p>G209-2M; gp100 (209-217) is a high-purity synthetic peptide designed for cancer immunotherapy research. The product specifications, including CAS number, molecular formula, molecular weight, and other key details, are available upon request from the supplier. This peptide is a critical tool for studies in oncology, immunology, and therapeutic vaccine development.<br/></p>

SupplierGlobal Technology Co., Ltd.www.hqtechtirz.com

View on supplier website More from this supplier

Source categories

Peptides

About this product

Product information from the supplier.

TECHNICAL SPECIFICATIONS

Item	Specification
Product Name	G209-2M; gp100 (209-217)
CAS NO.
Appearance	White to off-white lyophilized powder
Molecular Formula	C47H74N10O14S
Molecular Weight	1035.24g/mol
Amino Acid Sequence	IMDQVPFSV (human gp100₉₀₀‑₃₁₇ epitope; may include modifications such as methylation at Met⁺, D-amino acid substitution, or C-terminal amidation)
Purity (RP-HPLC)	≥95.0%
Solubility	Soluble in DMSO, PBS, or other aqueous buffers; may require sonication or gentle heating
Endotoxin	≤1.0 EU/mg
Biological Activity	HLA-A*0201-restricted tumor-associated antigen peptide; used in cancer vaccine research, T-cell activation studies, and immunotherapy development for melanoma.
Storage Conditions	Store at –20°C, protected from light and moisture. For long-term storage, recommend –80°C.
Stock Location	Stock in USA
MOQ	10mg

1.MECHANISM OF ACTION

G209-2M; gp100 (209-217) functions as a tumor-associated antigen peptide that is presented by HLA-A*0201 molecules on antigen-presenting cells. This presentation activates specific cytotoxic T lymphocytes (CTLs), leading to targeted immune responses against melanoma and other cancers expressing the gp100 antigen.

2.PRODUCT INDICATIONS

This peptide is primarily used in research focused on melanoma immunotherapy, cancer vaccine development, and T-cell activation studies. It is also employed in immunological assays, epitope mapping, and preclinical evaluation of adoptive cell therapies.

3.CLINICAL EFFICACY OF PRODUCT

Preclinical and clinical studies have shown that vaccines and therapies utilizing the gp100 (209-217) epitope can induce antigen-specific T-cell responses and contribute to tumor regression in melanoma patients. Its role in enhancing immune recognition of cancer cells supports its potential in combination immunotherapy approaches.

4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.